Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023)
Lineage Cell Therapeutics' (LCTX) quarterly Deferred Taxes came in at -$1.8 million in Q1 2023, down 77.87% quarter-over-quarter from -$1.0 million in Q3 2021.
Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023) Analysis & Trends
Lineage Cell Therapeutics' Deferred Taxes history runs 8 years deep, the most recent figure standing at -$1.8 million for Q1 2023.
- On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$1.8 million in Q1 2023; TTM through Dec 2023 was -$1.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$5.3 million, changed N/A from the prior year.
- Deferred Taxes slipped to -$1.8 million in Q1 2023 per LCTX's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $6.7 million in Q4 2019 and bottomed at -$4.4 million in Q1 2019.
- The 4-year median for Deferred Taxes is -$1.0 million (2021), against an average of -$467888.9.
- Across the five-year window, Deferred Taxes soared 79.82% in 2020 and sank 406.0% in 2021, its largest moves.
- Year by year, Deferred Taxes stood at $6.7 million in 2019, then plunged by 115.95% to -$1.1 million in 2020, then gained by 4.62% to -$1.0 million in 2021, then sank by 77.87% to -$1.8 million in 2023.
- Per Business Quant, the three latest LCTX Deferred Taxes figures stand at -$1.8 million (Q1 2023), -$1.0 million (Q3 2021), and -$169000.0 (Q2 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1.80 Mn |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -169,000.00 |
| Dec 31, 2020 | -1.06 Mn |
| Sep 30, 2020 | -200,000.00 |
| Dec 31, 2019 | 6.65 Mn |
| Sep 30, 2019 | -991,000.00 |
| Jun 30, 2019 | -1.25 Mn |
| Mar 31, 2019 | -4.38 Mn |
| Dec 31, 2017 | -5.00 Mn |
| Sep 30, 2017 | 4.77 Mn |
| Mar 31, 2017 | 3.88 Mn |
| Dec 31, 2015 | -1.12 Mn |
| Sep 30, 2015 | -948,000.00 |
| Jun 30, 2015 | -1.27 Mn |
| Mar 31, 2015 | -1.18 Mn |
| Dec 31, 2014 | -2.20 Mn |
| Sep 30, 2014 | -2.31 Mn |
| Jun 30, 2014 | -1.51 Mn |
| Mar 31, 2014 | -1.35 Mn |